Global Orphan Drugs Market Professional Survey Report 2016

 Table of Contents


1 Industry Overview of Orphan Drugs
    1.1 Definition and Specifications of Orphan Drugs
        1.1.1 Definition of Orphan Drugs
        1.1.2 Specifications of Orphan Drugs
    1.2 Classification of Orphan Drugs
    1.3 Applications of Orphan Drugs
        1.3.1 Hospital use
        1.3.2 Clinic use
        1.3.3 Others
    1.4 Industry Chain Structure of Orphan Drugs
    1.5 Industry Overview and Major Regions Status of Orphan Drugs
        1.5.1 Industry Overview of Orphan Drugs
        1.5.2 Global Major Regions Status of Orphan Drugs
    1.6 Industry Policy Analysis of Orphan Drugs
    1.7 Industry News Analysis of Orphan Drugs

2 Manufacturing Cost Structure Analysis of Orphan Drugs
    2.1 Raw Material Suppliers and Price Analysis of Orphan Drugs
    2.2 Equipment Suppliers and Price Analysis of Orphan Drugs
    2.3 Labor Cost Analysis of Orphan Drugs
    2.4 Other Costs Analysis of Orphan Drugs
    2.5 Manufacturing Cost Structure Analysis of Orphan Drugs
    2.6 Manufacturing Process Analysis of Orphan Drugs

3 Technical Data and Manufacturing Plants Analysis of Orphan Drugs
    3.1 Capacity and Commercial Production Date of Global Orphan Drugs Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global Orphan Drugs Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global Orphan Drugs Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global Orphan Drugs Major Manufacturers in 2015

4 Global Orphan Drugs Overall Market Overview
    4.1 2011-2016E Overall Market Analysis
        4.2.1 2011-2015 Global Orphan Drugs Capacity and Growth Rate Analysis
        4.2.2 2015 Orphan Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2011-2015 Global Orphan Drugs Sales and Growth Rate Analysis
        4.3.2 2015 Orphan Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2011-2015 Global Orphan Drugs Sales Price
        4.4.2 2015 Orphan Drugs Sales Price Analysis (Company Segment)
    4.5 Gross Margin Analysis
        4.5.1 2011-2015 Global Orphan Drugs Gross Margin
        4.5.2 2015 Orphan Drugs Gross Margin Analysis (Company Segment)

5 Orphan Drugs Regional Market Analysis
    5.1 North America Orphan Drugs Market Analysis
        5.1.1  North America Orphan Drugs  Market Overview
        5.1.2  North America 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3  North America 2011-2016E Orphan Drugs Sales Price Analysis
        5.1.4  North America 2015 Orphan Drugs Market Share Analysis
    5.2 Europe Orphan Drugs Market Analysis
        5.2.1  Europe Orphan Drugs  Market Overview
        5.2.2  Europe 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3  Europe 2011-2016E Orphan Drugs Sales Price Analysis
        5.2.4  Europe 2015 Orphan Drugs Market Share Analysis
    5.3 Japan Orphan Drugs Market Analysis
        5.3.1  Japan Orphan Drugs  Market Overview
        5.3.2  Japan 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3  Japan 2011-2016E Orphan Drugs Sales Price Analysis
        5.3.4  Japan 2015 Orphan Drugs Market Share Analysis
    5.4 China Orphan Drugs Market Analysis
        5.4.1  China Orphan Drugs  Market Overview
        5.4.2  China 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3  China 2011-2016E Orphan Drugs Sales Price Analysis
        5.4.4  China 2015 Orphan Drugs Market Share Analysis
    5.5 Southeast Asia Orphan Drugs Market Analysis
        5.5.1  Southeast Asia Orphan Drugs  Market Overview
        5.5.2  Southeast Asia 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3  Southeast Asia 2011-2016E Orphan Drugs Sales Price Analysis
        5.5.4  Southeast Asia 2015 Orphan Drugs Market Share Analysis
    5.6 India Orphan Drugs Market Analysis
        5.6.1  India Orphan Drugs  Market Overview
        5.6.2  India 2011-2016E Orphan Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3  India 2011-2016E Orphan Drugs Sales Price Analysis
        5.6.4  India 2015 Orphan Drugs Market Share Analysis

6 Global 2011-2016E Orphan Drugs Segment Market Analysis (by Type)
    6.1 Global 2011-2016E Orphan Drugs Sales by Type
    6.2 Different Types Orphan Drugs Product Interview Price Analysis
    6.3 Different Types Orphan Drugs Product Driving Factors Analysis

7 Global 2011-2016E Orphan Drugs Segment Market Analysis (by Application)
    7.1 Global 2011-2016E  Consumption by Application
    7.2 Different Application  Product Interview Price Analysis
    7.3 Different Application  Product Driving Factors Analysis
        7.3.1 Hospital use Orphan Drugs Growth Driving Factor Analysis
        7.3.2 Clinic use Orphan Drugs Growth Driving Factor Analysis
        7.3.3 Others Orphan Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Orphan Drugs
    8.1 Novartis
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
        8.1.3 Novartis 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novartis 2015 Orphan Drugs Business Region Distribution Analysis
    8.2 Roche
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
        8.2.3 Roche 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Roche 2015 Orphan Drugs Business Region Distribution Analysis
    8.3 Pfizer
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
        8.3.3 Pfizer 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Pfizer 2015 Orphan Drugs Business Region Distribution Analysis
    8.4 Sanofi
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
        8.4.3 Sanofi 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Sanofi 2015 Orphan Drugs Business Region Distribution Analysis
    8.5 Bristol Myers Squibb
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
        8.5.3 Bristol Myers Squibb 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Bristol Myers Squibb 2015 Orphan Drugs Business Region Distribution Analysis
    8.6 Eli Lilly
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
        8.6.3 Eli Lilly 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Eli Lilly 2015 Orphan Drugs Business Region Distribution Analysis
    8.7 Glaxosmithkline
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
        8.7.3 Glaxosmithkline 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Glaxosmithkline 2015 Orphan Drugs Business Region Distribution Analysis
    8.8 Merck
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
        8.8.3 Merck 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Merck 2015 Orphan Drugs Business Region Distribution Analysis
    8.9 Teva Pharmaceutical
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
        8.9.3 Teva Pharmaceutical 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Teva Pharmaceutical 2015 Orphan Drugs Business Region Distribution Analysis
    8.10 Takeda Pharmaceutical
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
        8.10.3 Takeda Pharmaceutical 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Takeda Pharmaceutical 2015 Orphan Drugs Business Region Distribution Analysis
    8.11 Celgene Corporation
        8.11.1 Company Profile
        8.11.2 Product Picture and Specifications
        8.11.3 Celgene Corporation 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.11.4 Celgene Corporation 2015 Orphan Drugs Business Region Distribution Analysis
    8.12 Johnson & Johnson
        8.12.1 Company Profile
        8.12.2 Product Picture and Specifications
        8.12.3 Johnson & Johnson 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.12.4 Johnson & Johnson 2015 Orphan Drugs Business Region Distribution Analysis
    8.13 Bayer
        8.13.1 Company Profile
        8.13.2 Product Picture and Specifications
        8.13.3 Bayer 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.13.4 Bayer 2015 Orphan Drugs Business Region Distribution Analysis
    8.14 Prosensa
        8.14.1 Company Profile
        8.14.2 Product Picture and Specifications
        8.14.3 Prosensa 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.14.4 Prosensa 2015 Orphan Drugs Business Region Distribution Analysis
    8.15 Genzyme Corporation
        8.15.1 Company Profile
        8.15.2 Product Picture and Specifications
        8.15.3 Genzyme Corporation 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.15.4 Genzyme Corporation 2015 Orphan Drugs Business Region Distribution Analysis
    8.16 Alexion
        8.16.1 Company Profile
        8.16.2 Product Picture and Specifications
        8.16.3 Alexion 2015 Orphan Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.16.4 Alexion 2015 Orphan Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of  Market
    9.1 Global  Market Trend Analysis
        9.1.1 Global 2016-2021  Market Size (Volume and Value) Forecast
        9.1.2 Global 2016-2021  Sales Price Forecast
        9.1.3 Global 2016-2021  Gross Margin Forecast
    9.2  Regional Market Trend
        9.2.1 North America 2016-2021 Orphan Drugs Consumption Forecast
        9.2.2 Europe 2016-2021 Orphan Drugs Consumption Forecast
        9.2.3 Japan 2016-2021 Orphan Drugs Consumption Forecast
        9.2.4 China 2016-2021 Orphan Drugs Consumption Forecast
        9.2.5 Southeast Asia 2016-2021 Orphan Drugs Consumption Forecast
        9.2.6 India 2016-2021 Orphan Drugs Consumption Forecast
    9.3  Market Trend (Product type)
    9.4  Market Trend (Application)

10 Orphan Drugs Marketing Model Analysis
    10.1 Orphan Drugs Regional Marketing Model Analysis
    10.2 Orphan Drugs International Trade Model Analysis
    10.3 Traders or Distributors with Contact Information of Orphan Drugs by Regions
    10.4 Orphan Drugs Supply Chain Analysis

11 Consumers Analysis of Orphan Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    �

12 New Project Investment Feasibility Analysis of Orphan Drugs
    12.1 New Project SWOT Analysis of Orphan Drugs
    12.2 New Project Investment Feasibility Analysis of Orphan Drugs

13 Conclusion of the Global Orphan Drugs Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy